Insider filing · RARE
Karah Herdman Parschauer
EVP and Chief Legal Officer
profile →
Ultragenyx Pharmaceutical Inc.
RARE · Healthcare · 28 filings in 24 months
ticker →
Karah Herdman Parschauer sold $541K of Ultragenyx Pharmaceutical (RARE)
Executed Mar 3 2025, disclosed Mar 4 2025, 1 day later.
Value, as filed
$541K
12,846 sh × $42.10
Executed
Mar 3 2025
the trade date, as filed
Disclosed
Mar 4 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
KPKarah Herdman Parschauer (EVP and Chief Legal Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Ultragenyx Pharmaceutical Inc. (RARE). The largest single filing was $185K of RARE (8,135 sh × $22.80, as filed), executed Mar 2.
The name
RAREHealthcare · Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Karah Herdman Parschauer in RARE
RARESALE
Ultragenyx Pharmaceutical Inc.
$129K6,018 sh × $21.40
Exec Mar 6
Filed Mar 10 · 5:30 PM ET RARESALE Ultragenyx Pharmaceutical Inc. $185K
8,135 sh × $22.80
Exec Mar 2
Filed Mar 3 · 5:30 PM ET